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Prognostic Value of Myocardial
iability Detected by Myocardial Contrast
chocardiography Early After Acute Myocardial Infarction
Girish Dwivedi, MD, MRCP, DM, Rajesh Janardhanan, MD, MRCP,
Sajad A. Hayat, MBCHB, MRCP, John M. Swinburn, MD, MRCP,
Roxy Senior, MD, DM, FRCP, FESC, FACC
Harrow, Middlesex, United Kingdom
Objectives This study sought to determine whether residual myocardial viability determined by myocardial contrast echocar-
diography (MCE) after acute myocardial infarction (AMI) can predict hard cardiac events.
Background Myocardial viability detected by MCE has been shown to predict recovery of left ventricular (LV) function in pa-
tients with AMI. However, to date no study has shown its value in predicting major adverse outcomes in AMI pa-
tients after thrombolysis.
Methods Accordingly, 99 stable patients underwent low-power MCE at 7  2 days after AMI. Contrast defect index (CDI)
was obtained by adding contrast scores (1  homogenous; 2  reduced; 3  minimal/absent opacification) in
all 16 LV segments divided by 16. At discharge, 65 (68%) patients had either undergone or were scheduled for
revascularization independent of the MCE result. The patients were subsequently followed up for cardiac death
and nonfatal AMI.
Results Of the 99 patients, 95 were available for follow-up. Of these, 86 (87%) underwent thrombolysis. During the
follow-up time of 46  16 months, there were 15 (16%) events (8 cardiac deaths and 7 nonfatal AMIs). Among
the clinical, biochemical, electrocardiographic, echocardiographic, and coronary arteriographic markers of prog-
nosis, the extent of residual myocardial viability was an independent predictor of cardiac death (p  0.01) and
cardiac death or AMI (p  0.002). A CDI of 1.86 and 1.67 predicted survival and survival or absence of re-
current AMI in 99% and 95% of the patients, respectively.
Conclusions The extent of residual myocardial viability predicted by MCE is a powerful independent predictor of hard car-
diac events in patients after AMI. (J Am Coll Cardiol 2007;50:327–34) © 2007 by the American College of
Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.03.036r
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pcute myocardial infarction (AMI) continues to be a
ignificant public health problem in industrialized countries
nd an increasingly significant problem in developing coun-
ries (1). The estimated mortality, although declining, still
emains high, and the risk of further cardiac complications
uch as reinfarction, sudden death, and heart failure for
hose who survive is substantial especially after thrombolysis
2). A proportion of patients manifest clinical features that
re associated with high risk, such as postinfarct angina,
eart failure, or hemodynamic instability, and these patients
equire an aggressive invasive management strategy. The
rom the Department of Cardiovascular Medicine, Northwick Park Institute of
edical Research, Northwick Park Hospital, Harrow, Middlesex, United Kingdom.
upported by a grant from the Cardiac Research Fund, Northwick Park Institute of
edical Research, Harrow, United Kingdom.h
Manuscript received January 16, 2007; revised manuscript received March 1, 2007,
ccepted March 12, 2007.emaining patients who are asymptomatic, however, have a
road spectrum of risk that is not clinically apparent, and
eed further investigation to elucidate the extent of this risk
hat is likely to influence subsequent management strategy.
esting left ventricular ejection fraction (LVEF) is a well-
ecognized and important marker of prognosis. However, in
he early postinfarct period, the resting LVEF is likely to
nderestimate the true contractile potential of the ventricle
ecause of uncoupling of viability and function (3). Myo-
ardial viability determined by dobutamine stress echocar-
iography (DSE) and radionuclide perfusion imaging have
een shown to predict outcome independent of LVEF after
MI (4–6).
Myocardial contrast echocardiography (MCE) is a rela-
ively new bedside technique that can assess myocardial
erfusion using microbubbles (7–9). Both animal as well as
uman studies have indicated that MCE can be used
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hence myocardial viability (8–
13). Unlike DSE, MCE can de-
tect myocardial viability at rest,
and unlike radionuclide perfu-
sion imaging, MCE has no radi-
ation burden and can be per-
formed at the bedside. Recent
studies have indicated that myo-
cardial viability assessed by MCE
can predict recovery of left ven-
tricular (LV) function in patients
after AMI (8,14). However, to
date no study has investigated
the value of myocardial viability
determined by MCE in predict-
ing prognosis after AMI in a
population in which thromboly-
sis is a major form of acute reper-
fusion therapy.
Therefore, this study was conducted to determine
hether residual myocardial viability determined by MCE
fter AMI can predict hard cardiac events over and above
hat predicted by clinical, electrocardiographic, biochemical
arkers and resting LV function parameters, which are
requently used clinical markers of prognosis.
ethods
atient population. Consecutive stable patients shortly
fter their first presentation with AMI were enrolled. The
iagnosis of AMI was based on patients satisfying 2 of 3
riteria: 1) typical anginal pain lasting for 30 min; 2)
ersistent ST-segment elevation electrocardiogram; and 3) a
reatine kinase measurement of 2 times the upper limit of
ormal. The Hospital Ethics Committee approved the
rotocol. All patients gave informed consent before entering
he study.
tudy protocol. Within 7  2 days after AMI, all patients
nderwent simultaneous baseline transthoracic echocardi-
graphy and low-power MCE for the estimation of LVEF
nd LV volumes. The decision to proceed to coronary
rteriography and revascularization was based on clinical
rounds (medical comorbidity, suitability of coronary anat-
my, patients preference, and so on) independent of MCE
esults.
chocardiography. Resting echocardiography was under-
aken using tissue harmonic imaging (Hewlett-Packard
onos-5500, Best, the Netherlands). The American Society
f Echocardiography 16-segment LV model was used for
nalysis. Wall thickening was graded by transthoracic echo-
ardiography using a 4-point scoring system (1  normal,
 reduced, 3  absent, 4  systolic wall thinning). The
VEF, left ventricular end-diastolic volume (LVEDV), and
eft ventricular end-systolic volume (LVESV) were assessed
Abbreviations
and Acronyms
AMI  acute myocardial
infarction
CAD  coronary artery
disease
CDI  contrast defect
index
DSE  dobutamine stress
echocardiography
LV  left ventricular
LVEDV  left ventricular
end-diastolic volume
LVEF  left ventricular
ejection fraction
LVESV  left ventricular
end-systolic volume
MCE  myocardial contrast
echocardiographysing the modified Simpson biplane method (15). dCE. The MCE was performed in the 3 standard apical
4-, 2-, and 3-chamber) views using a low-power technique
t a mechanical index of 0.1. Background gains were set so
hat minimal tissue signal was seen, and the focus was set at
he level of the mitral valve. For the first 40 patients,
ptison (Amersham Health, Little Chalfont, United King-
om) was given as a slow bolus injection of 0.3 to 0.7 ml
ollowed by a saline flush over 20 s (8). The remaining 59
atients were studied using Sonovue (Bracco Research SA,
eneva, Switzerland); this was administered as an intrave-
ous infusion at 50 to 70 ml/h using a VueJect (BR-INF
00, Bracco Research SA, Geneva, Switzerland) infusion
ump. Machine settings were optimized to obtain the best
ossible myocardial opacification with minimal attenuation.
eplenishment was observed for at least 15 cardiac cycles
fter high mechanical index (1.7) microbubble destruc-
ion (8).
A semiquantitative scoring system that has been previ-
usly validated in our laboratory (8) was used to assess
ontrast intensity after microbubble destruction; 1  ho-
ogenous opacification, 2  heterogenous opacification,
 minimal or absent contrast opacification. We have
reviously performed interobserver and intraobserver vari-
bility analysis using the above scores in these patients, and
he results are 89% (k  0.76) and 90% (k  0.77)
espectively using the same technique (13). Contrast defect
ndex (CDI) was obtained by adding contrast scores of all
egments and dividing by the total number of evaluable
egments. The CDI represented the extent and intensity of
esidual infarction and thus residual myocardial viability.
ercentages of segments with heterogeneous opacification
patchy infarction) and absent contrast opacification (com-
lete infarction) also were obtained for each patient. An
xperienced reader blinded to the clinical and angiographic
etails performed analysis of echocardiographic data. The
CE and LV function data were assessed separately.
oronary arteriography. Selective coronary arteriography
as performed with the Judkins approach. Coronary artery
isease (CAD) was defined as a 50% luminal diameter
arrowing of one or more major epicardial arteries or their
ajor branches assessed qualitatively. The presence of CAD
as determined in the left anterior descending (anterior)
irculation and the right coronary artery and/or left circum-
ex (posterior) circulation. Mean coronary luminal diameter
tenosis and number of coronary vessels showing significant
AD were calculated.
utcome and follow-up. Study patients were followed up
or at least 6 months in a dedicated clinic where a research
ellow and a nurse reviewed study patients for events. The
ospital data base was checked and the patient’s general
ractitioner was contacted in case of nonattendance. Sub-
equent follow-up data were collected by questionnaires
eturned from patients with an additional telephone call or
ospital record review to further verify events wherever
ppropriate. The vital status of all screened patients was
etermined from the hospital patient information system at
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July 24, 2007:327–34 Prognostic Value of Contrast Echocardiographyhe termination of the study. Primary study end points were:
) cardiac death (defined as sudden death caused by AMI or
rrhythmia or heart failure); and 2) cardiac death or nonfatal
MI (typical chest pain and increased troponin I). How-
ver, if a patient suffered both of the events, then cardiac
eath was recorded as the primary event.
tatistical Analysis
ll categorical variables are expressed as proportions/
ercentages, and all continuous variables as mean  SD,
xcept those that are not normally distributed, which are
resented as medians with 95% confidence intervals
CIs). Positively skewed variables were log transformed
or further analysis. Differences between means were
alculated using an unpaired t test. Cox regression
nalysis was used to examine the effect of prognostic
ariables listed in Table 1 on time to outcome. However,
hen all subjects in a particular group had the same
utcome, then a Fisher exact test was used. To examine
he joint effect of the explanatory variables, multivariate
nalysis was then performed using Cox models. A back-
ard selection procedure was used to retain only the
tatistically significant variables. To limit the number of
ariables, only variables that gave a p value of 0.2 from
he univariate analyses were considered for the multivar-
ate analyses. A receiver-operator characteristic analysis
as used to test the predictive accuracy of MCE param-
ters. Optimal cutoff was defined as the threshold where
he sum of sensitivity and specificity was maximum. A p
alue of 0.05 was considered statistically significant.
atient Characteristics
Table 1 Patient Characteristics
n 99
Age, yrs 61 10.8
Male 72 (76%)
Diabetes 25 (26%)
Hypertension 31 (32%)
Smoker 40 (42%)
Family history of CAD 26 (27%)
Hypercholesterolemia 42 (44%)
Past history of CAD 9 (10%)
Peak creatine kinase (IU/l) 1,561 1,321
Anterior infarction 67 (71%)
Q-wave 73 (77%)
Thrombolysis 86 (87%)
Revascularization 65 (68%)
LVEDV (ml) 106 41
LVESV (ml) 54 29
LVEF (%) 50 11
Percentage segments with score of 2 (patchy infarct) 7.5 10
Percentage segments with score of 3 (complete infarct) 21 20
Contrast defect index 1.50 0.38
Luminal diameter stenosis of coronary artery (%) 84 12
Number of diseased vessels on coronary arteriography 1.8 0.99
AD  coronary artery disease; LVEDV  left ventricular end-diastolic volume; LVEF  left
entricular ejection fraction; LVESV  left ventricular end-systolic volume.esults
atients characteristics and outcome. A total of 99 pa-
ients were enrolled, out of which 4 patients were lost to
ollow-up. The remaining 95 patients were considered for
he final analysis. Patient characteristics of these 95 patients
re listed in Table 1. Of the 95 patients, 86 (87%)
nderwent thrombolysis. Mean LVEF was 50%  11%.
oronary arteriography was performed in 86 (87%) patients;
7 (87%) patients had significant CAD of the infarct-
elated artery, and 35 (40%) showed evidence of multivessel
isease. At discharge, 65 (68%) patients had either under-
one or were scheduled for revascularization independent of
he MCE result. The MCE scores were obtained in all
atients. The mean time from presentation to revascular-
zation was 46  64 days. The remaining patients, i.e. 30
32%) patients, were not revascularized on medical grounds.
he mean duration of follow-up was 46  16 months.
dverse cardiac events occurred in 15 patients (16%), of
hom 8 (8%) died and 7 (8%) had nonfatal AMI.
rediction of cardiac mortality. Prediction of cardiac
ortality is shown in Table 2. Of the prognostic variables
utlined in Table 1, the univariable predictors of cardiac
eath were elevated CDI (hazard ratio [HR] 1.27, 95% CI
.06 to 1.53, p  0.006), LVESV (HR 1.25, 95% CI 1.04
o 1.51, p  0.02), and LVEF (HR 0.46, 95% CI 0.26 to
.89, p  0.009). The results indicated that higher LVESV
as associated with a greater risk of death at any time. It was
ound that a 10-U increase in LVESV resulted in the hazard
or risk) of death at any time increasing by 25%. Conversely,
igher values of LVEF were associated with a decreased risk
f death. A 10-U increase in LVEF resulted in the hazard
f death decreasing by over half. Among the MCE param-
ters, CDI emerged as the strongest univariate predictor.
igher CDI values were associated with an increased
azard of death at any time. A 0.1-U increase in CDI
esulted in the hazard of death at any time increasing by
7%. As other parameters of MCE, i.e., percentage of
atchy infarction and complete infarction, are strongly
nterrelated with CDI, which is the strongest univariate
redictor, CDI was entered in the multivariate model.
The multivariable predictors of cardiac death were in-
reased age (HR 3.43, 95% CI 1.27 to 9.27, p  0.02),
ean coronary luminal diameter stenosis (HR 2.97, 95% CI
.12 to 7.81, p  0.03), and elevated CDI (HR 1.37, 95%
I 1.08 to 1.75, p  0.01). A 0.1-U increase in CDI
esulted in the hazard of death at any time increasing by
7%. A 10-unit increase in mean stenosis was associated
ith the hazard of death increasing almost threefold,
hereas a 10-year increase in age was associated with the
azard of death at any time increasing over 3-fold.
rediction of cardiac death or nonfatal AMI. Prediction of
ardiac death or nonfatal AMI is shown in Table 3. Univari-
ble predictors of cardiac death or nonfatal AMI were LVESV
HR 1.17, 95% CI 1.01 to 1.36, p  0.04), LVEF (HR 0.59,
5% CI 0.38 to 0.90, p  0.01) and elevated CDI (HR 1.20,
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ad an increased likelihood of death or nonfatal AMI at any
ime. A 10-U increase in volume resulted in the hazard of
eath or nonfatal AMI increasing by 17%. High values of
VEF were associated with a lower risk of death or nonfatal
ox Model for Predictors of Cardiac Death
Table 2 Cox Model for Predictors of Cardiac Death
Variables
Age p  0.06, H
Male p  0.43, H
Diabetes p  0.44, H
Hypertension p  0.22, H
Smoker p  0.35, H
Family history of CAD p  0.95, H
Hypercholesterolemia p  0.31, H
Past history of CAD p  0.99, H
Peak creatine kinase (IU/l) p  0.94, H
Anterior infarction p  0.10†
Q-wave p  0.49, H
Thrombolysis p  0.34, H
Revascularization p  0.05, H
LVEDV (ml) p  0.14, H
LVESV (ml) p  0.02, H
LVEF (%) p  0.009,
Patchy infarct (%) p  0.14, H
Complete infarct (%) p  0.04, H
Contrast defect index p  0.006,
Luminal diameter stenosis of coronary artery (%) p  0.08, H
Number of diseased vessels on coronary arteriography p  0.57, H
HR expressed as per 10 years. †Analysis performed as Fisher exact test.
CI  confidence interval; HR  hazard ratio; other abbreviations as in Table 1.
ox Model for Predictors of Cardiac Death or Nonfatal Acute Myoc
Table 3 Cox Model for Predictors of Cardiac Death or Nonfatal
Variables
Age p  0.38, HR
Male p  0.42, HR
Diabetes p  0.68, HR
Hypertension p  0.26, HR
Smoker p  0.20, HR
Family history of CAD p  0.77, HR
Hypercholesterolemia p  0.71, HR
Past history of CAD p  0.99, HR
Peak creatine kinase (IU/l) p  0.49, HR
Anterior infarction p  0.08, HR
Q-wave p  0.21, HR
Thrombolysis p  0.39, HR
Revascularization p  0.06, HR
LVEDV (ml) p  0.17, HR
LVESV (ml) p  0.04, HR
LVEF (%) p  0.01, HR
Patchy infarct (%) p  0.58, HR
Complete infarct (%) p  0.04, HR
Contrast defect index p  0.008, H
Luminal diameter stenosis of coronary artery (%) p  0.18, HR
Number of diseased vessels on coronary arteriography p  0.89, HRHR expressed as per 10 years.
Abbreviations as in Tables 1 and 2.MI at any time. A 0.1-U increase in CDI increased risk of
eath or nonfatal AMI by 20%. However, when multivariable
nalysis was performed, only elevated CDI emerged as a
ignificant predictor (HR 1.26, 95% CI 1.09 to 1.44, p 
.002) of death or nonfatal AMI.
ivariable Multivariable
.13,* 95% CI 0.98–4.61 p  0.02, HR  3.43,* CI 1.27–9.27
.68, 95% CI 0.06–2.34
.77, 95% CI 0.42–7.44
.27, 95% CI 0.03–2.21
.47, 95% CI 0.09–2.32
.95, 95% CI 0.19–4.72
.44, 95% CI 0.09–2.19
.00, 95% CI 0.12–8.28
.03, 95% CI 0.48–2.21
.08, 95% CI 0.26–16.9
.34, 95% CI 0.34–12.1
.24, 95% CI 0.06–1.02
.11, 95% CI 0.96–1.29
.25, 95% CI 1.04–1.51
0.46, 95% CI 0.26–0.89
.86, 95% CI 0.72–1.04
.04, 95% CI 1.00–1.08
1.27, 95% CI 1.06–1.53 p  0.01, HR  1.37, 95% CI 1.08–1.75
.16, 95% CI 0.91–5.12 p  0.03, HR  2.96, 95% CI 1.12–7.81
.65, 95% CI 0.15–2.90
l Infarction
e Myocardial Infarction
ariable Multivariable
5,* 95% CI 0.76–2.04
9, 95% CI 0.08–2.98
8, 95% CI 0.40–4.12
7, 95% CI 0.13–1.72
3, 95% CI 0.12–1.56
3, 95% CI 0.23–2.99
1, 95% CI 0.27–2.47
9, 95% CI 0.22–4.51
2, 95% CI 0.69–2.18
6, 95% CI 0.02–1.21
8, 95% CI 0.48–28.2
4, 95% CI 0.32–10.1
6, 95% CI 0.12–1.04
8, 95% CI 0.97–1.20
7, 95% CI 1.01–1.36
9, 95% CI 0.38–0.90
8, 95% CI 0.92–1.05
3, 95% CI 1.00–1.06
20, 95% CI 1.05–1.36 p  0.002, HR  1.26, 95% CI 1.09 to 1.44
4, 95% CI 0.85–2.44
3, 95% CI 0.35–4.36Un
R  2
R  0
R  1
R  0
R  0
R  0
R  0
R  1
R  1
R  2
R  2
R  0
R  1
R  1
HR 
R  0
R  1
HR 
R  2
R  0ardia
Acut
Univ
 1.2
 0.7
 1.2
 0.4
 0.4
 0.8
 0.8
 0.9
 1.2
 0.1
 3.6
 2.2
 0.3
 1.0
 1.1
 0.5
 0.9
 1.0
R  1.
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 1.2
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haracteristic curve analyses showing sensitivity and speci-
city of different cutoff points with CDI for the predictions
f death and death or nonfatal AMI were performed. The
reas under the receiver-operator characteristic curve with
DI for the predictions of death (Fig. 1A) and death or
onfatal AMI (Fig. 1B) were 0.82 and 0.80, respectively. A
DI value of 1.86 provided the optimum cutoff, with
ensitivity and specificity of 87% and 84% for cardiac death
nd 62% and 84% for cardiac death or nonfatal AMI,
espectively.
aplan-Meier survival curve analysis. Kaplan-Meier sur-
ival curve analysis was performed using a cutoff CDI of
.86 for the prediction of cardiac death (Fig. 2A) and a
utoff CDI of 1.67 for the prediction of cardiac death or
onfatal AMI (Fig. 2B). The log rank test showed that
atients with CDI 1.86 had a significantly (p  0.0001)
Figure 1 Receiver-Operator Characteristic Curve
(A) Receiver-operator characteristic curve showing different cutoff points with
CDI for the prediction of cardiac death. (B) Receiver-operator characteristic
curve showing different cutoff points with CDI for the prediction of cardiac
death or nonfatal AMI. AMI  acute myocardial infarction; CDI  contrast
defect index; NPV  negative predictive value; PPV  positive predictive value.wigh cardiac mortality (33%), compared with only 1% in
atients with CDI 1.86. Similarly, patients with a CDI
1.67 had a significantly higher incidence of cardiac death
r nonfatal AMI (39%) compared with those with a CDI
1.67, who had an event rate of 5% over a 4-year follow-up
eriod. The CDI maintained its ability to predict cardiac
vents irrespective of the technique used. A CDI 1.67
eparated patients with and without cardiac events in both
he Optison (4% and 38%, respectively) and the Sonovue
5% and 44%, respectively) groups.
elationship between LVEF, infarct size, and prognosis. The
elationship between LVEF, infarct size, and prognosis is
hown in Figures 3 and 4. Of the 95 patients, 46 (48%) had
VEF 50%. Of these, the majority, i.e., 37 (80%), had a
nly small AMI defined as CDI 1.67. In this group, 5%
f the patients with a small infarction versus 20% with a
arge infarction suffered cardiac death or nonfatal AMI (p
.33). However, in patients with LVEF 50%, although
one with a small infarction had cardiac event, in patients
Figure 2 Kaplan-Meier Survival Curve
(A) Kaplan-Meier survival curve (unadjusted) using a cutoff of CDI of 1.86 for
the prediction of cardiac death. (B) Kaplan-Meier survival curve using a cutoff
of CDI of 1.67 for the prediction of cardiac death or nonfatal AMI. F/U  follow-up;
other abbreviations as in Figure 1.ith large infarctions, the incidence of cardiac events
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Prognostic Value of Contrast Echocardiography July 24, 2007:327–34ncreased significantly to 53% (p  0.002). This trend was
oted even in patients with a lower LVEF, i.e., 45% (p 
.015) and 40% (p  0.08).
iscussion
his is the first study showing that residual myocardial
iability as shown by low-power MCE is an independent
redictor of long-term hard cardiac events in patients after
MI. In this population, in which survival was 92% over a
-year follow-up period, the presence of myocardial viability
etermined by MCE predicted 99% survival, compared with
nly 67% survival in patients with no significant myocardial
iability. Whereas 39% of patients suffered either cardiac
eath or nonfatal AMI with no significant myocardial
iability, only 5% experienced such events in the presence of
ignificant myocardial viability in a population with a hard
Figure 3 Kaplan-Meier Survival Curve
(A) Kaplan-Meier survival curve in patients with preserved LVEF (i.e., 50%)
using a cutoff of CDI of 1.67 for the prediction of cardiac death or nonfatal
AMI. (B) Kaplan-Meier survival curve in patients with decreased LVEF (i.e.,
50%) using a cutoff of CDI of 1.67 for the prediction of cardiac death or non-
fatal AMI. LVEF  left ventricular ejection fraction; other abbreviations as in
Figures 1 and 2.ardiac event rate of 16% over 4 years. This study alsohowed that larger infarctions predict mortality, whereas
MI is more likely to occur in patients with relatively
maller infarctions and hence viable myocardium. It is
ntuitive that after AMI and thrombolysis, for a given
VEF, infarct size and inducible myocardial ischemia are
ikely to be the ultimate determinants of outcome.
The LVEF and LVESV, which reflect the extent
f infarction burden, were strong univariate predictors of
ortality or mortality and AMI, but only the extent of
nfarction assessed by MCE remained an independent
redictor of both outcomes. The LV function early after
MI tends to overestimate the extent of true infarction
ecause of myocardial stunning, which can persist for up to
weeks. Thus in our study, MCE, which assesses the extent
f infarction more directly than the parameters of LV
unction, provided the most prognostic information in
atients with LV dysfunction. Myocardial contrast echocar-
iography did not provide significant incremental informa-
ion over LV function parameters in patients with preserved
VEF, because in these patients most (80%) had only a
mall infarction, as already predicted by normal LV func-
ion. Several previous studies using radionuclide imaging
nd DSE, both of which also detect the extent of infarction
erformed early after AMI, have provided superior prog-
ostication compared with LV function, as also shown in
ur study using MCE (4–6). In our study, the severity of
AD, which is a marker of ischemia, was also an indepen-
ent predictor of cardiac death.
echanism of detection of myocardial viability by MCE.
yocardial contrast echocardiography detects contrast mi-
robubbles at the capillary level within the myocardium
16). When a steady state of microbubble concentration is
chieved in the myocardium during a contrast administra-
ion, the acoustic signal intensity observed provides a
easure of myocardial blood volume fraction. Because 90%
Figure 4 Incidence of Cardiac Events in Different LVEF Groups
Occurrence of cardiac death or nonfatal AMI in various
LVEF groups according to CDI. Abbreviations as in Figures 1 and 3.
o
b
c
C
c
fi
h
d
r
A
s
s
b
w
fl
i
m
b
t
p
(
R
m
A
d
i
i
o
s
s
(
d
e
a
v
C
D
o
v
n
t
r
s
v
v
c
a
s
f
o
t
i
p
i
e
r
p
l
w
b
S
p
N
t
g
v
n
u
C
T
M
p
R
p
d
K
R
1
1
333JACC Vol. 50, No. 4, 2007 Dwivedi et al.
July 24, 2007:327–34 Prognostic Value of Contrast Echocardiographyf myocardial blood volume fraction comprises capillary
lood, a single MCE image provides an assessment of
apillary density in the different myocardial regions (16).
ontrast signal intensity during MCE has been shown to
orrelate directly with capillary density and indirectly with
brosis in biopsied myocardium in patients with chronic
eart failure (17). Contrast perfusion assessed at 15 s during
estruction-replenishment imaging has been shown to cor-
elate well with ultimate infarct size in animal models of
MI (11,12). After AMI, collateral blood flow has been
hown to be generally less than normal flow in areas
howing myocardial viability (18,19). Regions with normal
lood flow fill within 5 s after destruction imaging. Regions
ith collateral flow fill later depending on the magnitude of
ow. If they do not fill within 15 s, then flow to the region
s markedly reduced and will result in necrosis (11). This
ethod of assessment of myocardial viability by MCE has
een shown to predict recovery of regional function and
ransmural extent of infarction, and also has been shown to
redict recovery of both regional and global LV function
8,13,14).
isk stratification after AMI. The most important deter-
inants of outcome in patients who are deemed stable after
MI and thrombolysis are resting LV function, extent and
egree of residual myocardial viability, and myocardial
schemia at the site of AMI or remote territory. The MCE
s a unique technique because it can address all of the above
utcome measures in a single examination. AnMCE during
tress testing has been shown to accurately detect the
everity of CAD in both the stable and the acute setting
20–24). In a recent study after AMI, MCE accurately
etected residual infarct related artery and multivessel dis-
ase, which also are strong prognostic markers of outcome
fter AMI (23). The present study confirms the prognostic
alue of MCE-determined myocardial viability after AMI.
linical implications. Radionuclide perfusion imaging,
SE, and late gadolinium-enhanced cardiac magnetic res-
nance are techniques widely used to assess myocardial
iability after AMI. However, MCE, compared with radio-
uclide perfusion imaging, is portable, can be performed at
he bedside, allows rapid acquisition of data, and has no
adiation burden. Compared with DSE, MCE has been
hown to be more sensitive for the detection of myocardial
iability after AMI, and unlike DSE can detect myocardial
iability at rest (25,26). Although gadolinium-enhanced
ardiac magnetic resonance has excellent spatial resolution,
recent study comparing the 2 modalities did not show any
ignificant difference in the prediction of recovery of LV
unction after AMI (13). Thus, with these advantages over
ther competitive techniques, MCE may well become the
echnique of choice for the assessment of myocardial viabil-
ty after AMI. In a recent study, after only anterior AMI
atients who underwent primary percutaneous coronary
ntervention, MCE predicted outcome but not hard cardiac
vents. The likely explanation could be a relatively lower-
isk study population, because all of them had undergone
1rimary percutaneous coronary intervention (27). However,
arger multicenter studies are required before MCE can be
idely recommended in the assessment of myocardial via-
ility after AMI and thrombolysis.
tudy limitations. Quantitative analysis of MCE was not
erformed, which may have made the data more robust.
evertheless, the objective of the study was to test whether
here was any clinical value in the use of a technique that
ives a rapid and accurate qualitative assessment of micro-
ascular perfusion. The study population is not large, but
evertheless, sufficient cardiac events had occurred to allow
s to conclude reasonably.
onclusions
he extent of residual myocardial viability predicted by
CE is a powerful predictor of hard cardiac events in
atients after AMI.
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